Overview

Comparing Efficacy and Safety of Inhaled SNG001 to Placebo

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
When people with asthma get respiratory virus such as a cold or flu it often increases asthma symptoms. The investigators will test the study medication to find out if it can prevent the virus spreading from the nose to the lungs. SNG001 contains Interferon-beta that occurs naturally in the body. In this study, SNG001 will be given by a nebuliser.
Phase:
Phase 2
Details
Lead Sponsor:
Synairgen Research Ltd.
Treatments:
Interferon beta-1a
Interferon-beta
Interferons